So­ci­etal CD­MO lands NCI pack­ag­ing deal for an­ti-tu­mor cap­sules fol­low­ing re­brand

4 years ago
Pharma
Manufacturing

Am­gen touts its lat­est cut of longterm Repatha da­ta, still hunt­ing elu­sive bil­lions for PC­SK9 fran­chise

4 years ago
Pharma

Mod­er­na CEO Stéphane Ban­cel plucks new com­mer­cial chief from Mer­ck­'s top ex­ec­u­tive team

4 years ago
People
Pharma

Pfiz­er and Bio­haven bring rimegepant to Eu­rope as mi­graine war with Ab­b­Vie heats up

4 years ago
Pharma

FDA pro­pos­es adding 'race and eth­nic­i­ty' cat­e­go­ry to ex­pand­ed ac­cess re­quests

4 years ago
FDA+

Lay­offs hit an­oth­er biotech as Duchenne play­er Sol­id Bio cuts staff by 35%

4 years ago
People
R&D

Covid-19 roundup: Pfiz­er-BioN­Tech ask for kid boost­er EUA; No­var­tis, Mol­e­c­u­lar Part­ners may need an­oth­er tri­al for ...

4 years ago
R&D
Coronavirus

NightHawk flies in­to na­tion­al stock­pile deal with Cana­di­an gov­ern­ment for an­thrax drug

4 years ago
Pharma
Manufacturing

Cal­adrius’ 16-year rocky his­to­ry bends again in Cend merg­er; Af­ter Cel­lec­tis, Chi­na JV pacts, Cy­tovia inks SPAC ...

4 years ago
Financing
Startups

Fen­nec looks for FDA ap­proval for hear­ing loss drug haunt­ed by man­u­fac­tur­ing prob­lems

4 years ago
FDA+
Manufacturing

Am­gen re-ups ESG re­port, out­lines lat­est ef­forts with fo­cus on ‘4 health­ies’

4 years ago
Pharma
Marketing

Pfiz­er nabs dis­count­ed stake in Zen­tal­is af­ter AACR22 da­ta left the biotech bruised

4 years ago
Financing
Pharma

No­var­tis records an­oth­er tislelizum­ab win en route to bring­ing BeiGene's PD-1 to FDA's doors

4 years ago
R&D
China

Am­gen kicks back I/O drug at cen­ter of $500M deal, leav­ing biotech part­ner alone to pon­der next steps

4 years ago
Deals

Can this tick bi­ol­o­gist and her team of ‘weirdo sci­ence’ en­thu­si­asts change the fu­ture of sci­en­tif­ic re­search?

4 years ago
People
Discovery

Scoop: Bridge­Bio's chief strat­e­gy of­fi­cer re­signs as the com­pa­ny qui­et­ly em­barks on an­oth­er round of lay­offs

4 years ago
R&D

CDER di­rec­tor on ac­cel­er­at­ed ap­proval re­forms and a court de­ci­sion that will 'send a chill' across rare dis­ease drug ...

4 years ago
FDA+

States may need to tweak gener­ic drug laws to in­crease ac­cess, re­searchers find

4 years ago
Pharma

Sanofi of­floads French rights for an­tipsy­chot­ic to neigh­bor­ing phar­ma

4 years ago
Deals
Pharma

NYU con­sid­ers hir­ing for­mer MIT sci­en­tist David Saba­ti­ni af­ter sex­u­al ha­rass­ment probe — re­port

4 years ago
People
Pharma

Sanofi en­lists an F1 rac­ing team to help op­ti­mize its man­u­fac­tur­ing op­er­a­tions

4 years ago
Pharma
Manufacturing

Vi­iV, Pfiz­er and Roche lead list for phar­ma rep­u­ta­tion ranked by pa­tient group, an­nu­al sur­vey finds

4 years ago
Pharma
Marketing

Malaysian gov­ern­ment en­lists na­tive Bio­con for in­sulin sup­ply deal

4 years ago
Manufacturing

Thou­sands of jobs are on the chop­ping block as No­var­tis lays out re­struc­tur­ing plans, M&A hunt for deals up to $2B

4 years ago
Pharma
First page Previous page 542543544545546547548 Next page Last page
A service from the Financial Times